Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-blockers: a time for reappraisal

M J Kendall1

  • 1Clinical Pharmacology Section, Department of Medicine, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK.

Journal of Human Hypertension
|January 12, 1999
PubMed
Summary

Beta-blockers play a crucial role in managing hypertension, especially for preventing cardiovascular complications like myocardial infarction. Evidence shows they effectively reduce coronary mortality and are well-tolerated, even in elderly patients and those with diabetes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Charles Dickens' favourite child and a new kind of ray.

Journal of clinical pharmacy and therapeutics·2016
Same author

Experimentally simulating high-rate behaviour: rate and temperature effects in polycarbonate and PMMA.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2014
Same author

Mechanics of particulate composites with glassy polymer binders in compression.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2014
Same author

Availability of methaqualone from commercial preparations: in vitro and in vivo studies in man.

British journal of clinical pharmacology·2012
Same author

An assessment of gastric emptying by breathalyser.

British journal of clinical pharmacology·2012
Same author

The influence of diphenhydramine on the absorption of methaqualone in man.

British journal of clinical pharmacology·2012

Area of Science:

  • Cardiology
  • Pharmacology
  • Hypertension Management

Background:

  • While not universally the most potent or best-tolerated antihypertensive drugs, beta-blockers are vital for managing patients with hypertension.
  • Effective blood pressure control reduces stroke incidence, but preventing coronary artery disease progression and its complications (myocardial infarct, sudden death, heart failure) is more challenging.

Purpose of the Study:

  • To evaluate the role of beta-blockers in preventing cardiovascular complications in hypertensive patients.
  • To assess the evidence for beta-blockers in reducing coronary mortality and their tolerability in specific patient groups.

Main Methods:

  • Review of existing clinical evidence and studies on beta-blocker efficacy and safety in hypertension management.
  • Analysis of data concerning the impact of beta-blockers on coronary mortality and cardiovascular events.

Main Results:

  • Beta-blockers, particularly lipophilic ones, demonstrate significant evidence for reducing coronary mortality.
  • Adverse effects of beta-blockers are often exaggerated; elderly patients, diabetics, and those with impaired left ventricular function benefit considerably from beta-blockade.
  • Low plasma concentrations of beta1-selective drugs are clinically effective and well-tolerated.

Conclusions:

  • Beta-blockers are essential for hypertensive patients at risk of cardiovascular complications, with strong evidence supporting their role in reducing coronary mortality.
  • The benefits of beta-blockade are significant across diverse patient populations, including the elderly, diabetics, and those with cardiac dysfunction.
  • Beta1-selective beta-blockers offer effective and well-tolerated treatment options at low plasma concentrations.

Related Experiment Videos